-+ 0.00%
-+ 0.00%
-+ 0.00%

Innovent Biologics Doses First Participant in Phase 1 Trial of Anti-IL-1RAP Antibody for Gout Flares

Reuters·12/10/2025 00:27:26

Please log in to view news